Naturally occurring Bruton's tyrosine kinase mutations have no dominant negative effect in an X-linked agammaglobulinaemia cellular model

Clinical and Experimental Immunology

Volumn 152, Issue 1, 2008, Pages 33-38

  Perez De Diego R ^a,b   Lopez Granados E ^b   Rivera, J ^a   Ferreira, A ^b   Fontan G ^b   Bravo, J ^a   Garcia Rodriguez Ma C ^b   Bolland, S ^c  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Bruton's tyrosine kinase; Calcium mobilization; DT40 cells; Gene therapy; X linked agammaglobulinaemia

Indexed keywords

B LYMPHOCYTE RECEPTOR; BRUTON TYROSINE KINASE; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY;

ARTICLE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL STRAIN DT40; CHILD; CLINICAL ARTICLE; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; INFANT; LYMPHOMA CELL LINE; MUTANT; PRIORITY JOURNAL; WILD TYPE; X LINKED AGAMMAGLOBULINEMIA;

AGAMMAGLOBULINEMIA; ANIMALS; CALCIUM; CHICKENS; CHILD; CHILD, PRESCHOOL; GENETIC DISEASES, X-LINKED; HUMANS; IMMUNOGLOBULIN M; INFANT; MALE; MUTAGENESIS, SITE-DIRECTED; MUTATION; MUTATION, MISSENSE; PROTEIN-TYROSINE KINASES; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 40449119359     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03589.x     Document Type: Article

References (38)

1. Lederman HM, Winkelstein JA. X-linked agammaglobulinemia: an analysis of 96 patients. Medicine (Baltimore) 1985 64 : 145 56.
2. McKinney RE Jr, Katz SL, Wilfert CM. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis 1987 9 : 334 56.
3. Ochs HD, Smith CI. X-linked agammaglobulinemia. A clinical and molecular analysis. Medicine (Baltimore) 1996 75 : 287 99.
4. Rawlings DJ, Saffran DC, Tsukada S et al. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 1993 261 : 358 61.
5. Thomas JD, Sideras P, Smith CI, Vorechovský I, Chapman V, Paul WE. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 1993 261 : 355 8.
6. Sideras P, Smith CI. Molecular and cellular aspects of X-linked agammaglobulinemia. Adv Immunol 1995 59 : 135 223.
7. Vetrie D, Vorechovsky I, Sideras P et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 1993 361 : 226 33.
8. Tsukada S, Rawlings DJ, Witte ON. Role of Bruton's tyrosine kinase in immunodeficiency. Curr Opin Immunol 1994 6 : 623 30.
9. Yamada N, Kawakami Y, Kimura H et al. Structure and expression of novel protein-tyrosine kinases, Emb and Emt, in hematopoietic cells. Biochem Biophys Res Commun 1993 192 : 231 40.
10. Smith CIE, Islam TC, Mattson PT, Mohamed AJ, Nore BF, Vihinen M. The Tec family of cytoplasmic tyrosine kinases: mammaliam Btk, Bmx, Itk, Tec, Txk and homologs in other species. Bioessays 2001 23 : 436 46.
11. Gaspar HB, Conley ME. Early B cell defects. Clin Exp Immunol 2000 119 : 383 9.
12. Conley ME, Puck JM. Definition of the gene loci in X-linked immunodeficiencies. Immunol Invest 1998 17 : 425 63.
13. Nahm MH, Paslay JW, Davie JM. Unbalanced X chromosome mosaicism in B cells of mice with X-linked immunodeficiency. J Exp Med 1983 158 : 920 31.
14. Sprent J, Bruce J. Physiology of B cells in mice with X-linked immunodeficiency (xid) III: disappearance of xid B cells in double bone marrow chimeras. J Exp Med 1984 160 : 711 23.
15. Rohrer J, Conley ME. Correction of X-linked immunodeficient mice by competitive reconstitution with limiting numbers of normal bone marrow cells. Blood 1999 94 : 3358 65.
16. Porpiglia AS, Rohrer J, Conley ME. Reconstitution of B cell function in murine models of immunodeficiency. Clin Immunol 2003 107 : 90 7.
17. Quan ZS, Dick RF, Regueiro B, Quintans J. B cell heterogeneity, II: transplantation resistance in xid mice which affects the ontogeny of B cell sub-populations. Eur J Immunol 1981 11 : 643 9.
18. Quintans J. The immune response of CBA/N mice and their F1 hybrids to 2,4,6-trinitrophenylated (TNP) antigens, I: analysis of the response to TNP-coupled lipopolysaccharide in vivo and at the clonal level. Eur J Immunol 1979 9 : 67 71.
19. Yu PW, Tabuchi RS, Kato RM et al. Sustained correction of B-cell development and function in a murine model of X-linked agammaglobulinemia (XLA) using retroviral-mediated gene transfer. Blood 2004 104 : 1281 90.
20. Conley ME. Diagnostic guidelines - an international consensus document. Clin Immunol 1999 93 : 189.
21. García Rodríguez MC, López-Granados E, Ferreira A, Fontán G. Molecular analysis of Bruton's tyrosine kinase gene in Spain. Mutation brief. Hum Mutat 2001 18 : 84 8.
22. Pérez de Diego R, López-Granados E, Pozo M et al. Bruton's tyrosine kinase is not essential for LPS-induced activation of human monocytes. J Allergy Clin Immunol 2006 117 : 1462 9.
23. Futatani T, Miyawaki T, Tsukada S et al. Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood 1998 91 : 595 602.
24. López-Granados E, Pérez de Diego R, Ferreira Cerdán A, Fontán Casariego G, García Rodríguez MC. A genotype-phenotype correlation study in a group of 54, X-linked agammaglobulinemia (XLA) patients. J Allergy Clin Immunol 2005 116 : 690 7.
25. Matsuda T, Takahashi-Tezuka M, Fukada T et al. Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines. Blood 1995 85 : 627 33.
26. Sato S, Katagiri T, Takaki S et al. IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases. J Exp Med 1994 180 : 2101 11.
27. Schmidt U, van den Akker E, Parren-van Amelsvoort M et al. Btk is required for an efficient response to erythropoietin and for SCF-controlled protection against TRAIL in erythroid progenitors. J Exp Med 2004 199 : 785 95.
28. Wang D, Feng J, Wen R et al. Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors. Immunity 2000 13 : 25 35.
29. Kurosaki T, Kurosaki M. Transphosphorylation of Bruton's tyrosine kinase on tyrosine 551 is critical for B cell antigen receptor function. J Biol Chem 1997 272 : 15595 8.
30. Mao C, Zhou M, Uckun FM. Crystal structure of Bruton's tyrosine kinase domain suggest a novel pathway for activation and provides insights into the molecular basis of X-linked agammaglobulinemia. J Biol Chem 2001 276 : 41435 43.
31. Nisitani S, Kato RM, Rawlings D, Witte ON, Wahl MI. In situ detection of activated Bruton's tyrosine kinase in the Ig signalling complex by phosphopeptide-specific monoclonal antibodies. Proc Natl Acad Sci USA 1999 96 : 2221 6.
32. Satterthwaite AB, Witte ON. The role of Bruton's tyrosine kinase in B-cell development and function: a genetic perspective. Immunol Rev 2000 175 : 120 7.
33. Horwood NJ, Mahon T, McDaid JP et al. Bruton's tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor alpha production. J Exp Med 2003 197 : 1603 11.
34. Kurosaki T, Maeda A, Ishiai M, Hashimoto A, Inabe K, Takata M. Regulation of the phospholipase C-gamma2 pathway in B cells. Immunol Rev 2000 176 : 19 29.
35. Conley ME, Broides A, Hernandez-Trujillo V et al. Genetic analysis of patients with defects in early B-cell development. Immunol Rev 2005 203 : 216 34.
36. Fukuda M, Kojima T, Kabayama H, Mikoshiba K. Mutation of the pleckstrin homology domain of Bruton's tyrosine kinase in immunodeficiency impaired inositol 1,3,4,5-tetrakisphosphate binding capacity. J Biol Chem 1996 271 : 30303 6.
37. Takata M, Kurosaki T. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma 2. J Exp Med 1996 184 : 31 40.
38. Feldhahn N, Rio P, Soh BN et al. Deficiency of Bruton's tyrosine kinase in B cell precursor leukemia cells. Proc Natl Acad Sci USA 2005 102 : 13266 71.